Skip to main content
. 2021 May 15;10(12):3848–3861. doi: 10.1002/cam4.3927

TABLE 3.

Lesion characteristics

Total number of lesions 662
Tumor location
Oropharynx 132 (19.9%)
Anterior wall / Posterior wall / Lateral wall / Superior wall 9/79/23/21
Hypopharynx 519 (78.4%)
Postcricoid / Pyriform sinus / Posterior wall 33/404/82
Larynx 7 (1.1%)
Laryngeal epiglottis / Laryngeal arytenoid / Aryepiglottic folds 4/2/1
Oral cavity 4 (0.6%)
Oral floor / Hard palate / Buccal mucosa 1/1/2
Macroscopic type
Flat / Elevated / Unknown 528 (79.8%) / 127 (19.2%) / 7 (1.1%)
Treatment methods
Endoscopic mucosal resection (EMR) 307 (46.2%)
Endoscopic submucosal dissection (ESD) 264 (39.7%)
Endoscopic laryngopharyngeal surgery (ELPS) 31 (4.7%)
Transoral videolaryngoscopic surgery (TOVS) 31 (4.7%)
Laser microlaryngeal surgery 17 (2.6%)
Direct mucosectomy 12 (1.8%)
Number of resected specimens
En bloc 490 (74.0%)
Piecemeal 172 (26.0%)
Number of segments obtained by piecemeal resection
2/3/4/5/6/7/8/9/10/11 85/39/13/11/10/7/3/1/2/1
Tumor diameter on endoscopic images, median (range) a 12 (1–75)
Tumor diameter of resected specimens, median (range) b 14 (1–60)
EMR / ESD / ELPS / TOVS / Other procedures 12 (1–45) / 15 (1–60) / 20 (2–58) / 16 (5–42) / 13 (3–50)
Endoscopic depth of invasion for resected lesions
Intraepithelial / Subepithelial / Difficult to evaluate 472 (71.0%) / 158 (23.8%) / 32 (4.8%)
Histopathological depth of invasion (central diagnosis)
Intraepithelial / Subepithelial 380 (57.4%) / 282 (42.6%)
T category
Tis / T1 / T2 / T3 / Unknown 380 (57.4%) / 181 (27.3%) / 89 (13.4%) / 11 (1.7%) / 1 (0.2%)
Lymphatic invasion 19 (2.9%)
Venous invasion 16 (2.4%)
Horizontal margin positive for cancer in the resected specimen 309 (46.7%)
Subsequent treatment immediately after initial transoral surgery 20 (3.0%)
a

Missing data for 29 patients.

b

Missing data for 1 patient.